Email Disclaimer

DO NOT SEND CONFIDENTIAL INFORMATION.

This website presents general information about Polsinelli and is not intended as legal advice nor should you consider it as such. You should not act upon this information without seeking professional counsel. Please keep in mind that merely contacting Polsinelli will not establish an attorney-client relationship. Polsinelli cannot represent you until the firm knows there would not be a conflict of interest, and the firm determines that it is otherwise able to accept the engagement. Accordingly, please do not send Polsinelli any information or documents until a formal attorney-client relationship has been established through an interview with an attorney and you get authorization in the form of an engagement letter from Polsinelli. Any information or documents sent prior to your receipt of an engagement letter cannot be treated as confidences, secrets or protected information of any nature.

Polsinelli uses cookies to improve site functionality and provide you with a better browsing experience. Detailed information about the use of cookies on this Site, and how you can decline them, is provided in our privacy policy. By using this Site, or clicking “Accept" you consent to the use of cookies.

Polsinelli invites you to join us for session one in a series exploring concerns with the “opioid epidemic." Opioid overdose led to the deaths of 33,000 people in the U.S. in 2015, almost half of which involved prescription opioids. Governmental and health related agencies are devoting significant energy and resources to reduce the quantity of controlled substances being prescribed. Concurrently, the DEA and Department of Justice have made enforcement relating to opioid prescribing a top priority by focusing on clinics, pharmacies and prescribing physicians. Practicing physicians need useful guidance in caring for patients for whom the use of prescription pain control is absolutely essential. This is a two part webinar series, it will provide practical guidance from health care lawyers at Polsinelli and the physician education experts at CPEP.

Key Learning Objectives:

Summary of guidance on opioid prescriptions, including CDC guidelines, FDA guidance and standards from the Federation of State Medical Boards

New Medicaid reimbursement policies that are intended to change patient care

New clinical studies concerning the use of opioids for chronic pain

The latest from law enforcement (the DEA and DOJ)

Clinical perspective on the interplay between standard of care and the (changing) regulatory environment

Resources available to provide education and assist in creating effective systems in today’s changing environment